Cerebral embolism.
D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications; D002114:Calcinosis / Q000150:complications; D002312:Cardiomyopathy, Hypertrophic / Q000150:complications; D002986:Clinical Trials as Topic; D004696:Endocarditis / Q000150:complications; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006330:Heart Defects, Congenital / Q000150:complications; D006338:Heart Neoplasms / Q000150:complications; D006350:Heart Valve Prosthesis / Q000009:adverse effects; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000188:drug therapy* / Q000209:etiology; D002546:Ischemic Attack, Transient / Q000188:drug therapy; D008945:Mitral Valve Prolapse / Q000150:complications; D008946:Mitral Valve Stenosis / Q000150:complications; D009232:Myxoma / Q000150:complications; D010974:Platelet Aggregation / Q000187:drug effects
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D001241:Aspirin